Curran Simpson, SVP, Product Development & CTO at REGENXBIO Inc. (RGNX), sold 113,986 shares at $51.37 ($5.7M) on 2020-02-11, disclosed to the SEC on 2020-02-12.
Open-market sale of $5.7M RGNX by SVP, Product Development & CTO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.22 | 44,429 | $2.2M | 38.9% |
| 2 | $50.22 | 44,429 | $2.2M | 38.9% |
| 3 | $50.13 | 8,872 | $445K | 7.8% |
| 4 | $50.13 | 8,872 | $445K | 7.8% |
| 5 | $51.37 | 3,692 | $190K | 3.3% |
| 6 | $51.37 | 3,692 |
| $190K |
| 3.3% |
| Total | $50.28 avg | 113,986 | $5.7M | 100% |
| Filing → |
| RGNX | SELL | 2025-09-12 | $155K | — | Filing → |
| RGNX | SELL | 2024-08-05 | $2K | — | Filing → |
| RGNX | SELL | 2024-07-30 | $290K | — | Filing → |